Nurix Therapeutics Inc Capital Reinvestment Ratio

Latest as of November 2023: 0.10x

Nurix Therapeutics Inc capital reinvestment ratio. Nurix Therapeutics Inc (NRIX) has a Capital Reinvestment Ratio of 0.10x as of November 2023, meaning it reinvests 0% of its operating cash flow ($26.69 Million) in capital expenditures ($2.58 Million). Check NRIX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.10x

Capex / Operating Cash Flow

Operating Cash Flow

$26.69 Million

USD

Capital Expenditures

$2.58 Million

USD

Data as of

Nov 2023

Most recent filing

Capital Reinvestment Ratio of Nurix Therapeutics Inc (2019–2019)

Capital reinvestment ratio of Nurix Therapeutics Inc from 2019 to 2019. This chart tracks Nurix Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Nurix Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.

Nurix Therapeutics Inc Capital Reinvestment Ratio by Year (2019–2019)

Nurix Therapeutics Inc capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see NRIX cash flow metrics.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2019	2.75x	$601.00K	$1.65 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow